Next Article in Journal
Haematoma Caused by Bone Marrow Aspiration and Trephine Biopsy
Previous Article in Journal
SIOG (International Society of Geriatric Oncology) Recommendations for Anthracycline Use in the Elderly
 
 
Hematology Reports is published by MDPI from Volume 14 Issue 1 (2022). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with PAGEPress.
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Sickle Cell Protection from Malaria

Department of Biomedical Science and Technology, University of Milan, Via Fratelli Cervi 93, 20090 Segrate (MI), Italy
Hematol. Rep. 2011, 3(3), e24; https://doi.org/10.4081/hr.2011.e24
Submission received: 27 July 2011 / Revised: 10 October 2011 / Accepted: 12 October 2011 / Published: 4 November 2011

Abstract

A linkage between presence of Sickle Haemoglobin (HbS) and protection from malaria infection and clinical manifestations in certain areas was suspected from early observations and progressively elucidated by more recent studies. Research has confirmed the abovementioned connection, but also clarified how such protection may be abolished by coexistence of sickle cell trait (HbS trait) and alpha thalassemia, which may explain the relatively low incidence of HbS trait in the Mediterranean. The mechanisms of such protective effect are now being investigated: factors of genetic, molecular and immunological nature are prominent. As for genetic factors attention is given to the role of the red blood cell (RBC) membrane complement regulatory proteins as polymorphisms of these components seem to be associated with resistance to severe malaria; genetic ligands like the Duffy group blood antigen, necessary for erythrocytic invasion, and human protein CD36, a major receptor for P. falciparum-infected RBC‘s, are also under scrutiny: attention is focused also on plasmodium erythrocyte-binding antigens, which bind to RBC surface components. Genome-wide linkage and association studies are now carried out too, in order to identify genes associated with malaria resistance. Only a minor role is attributed to intravascular sickling, phagocytosis and haemolysis, while specific molecular mechanisms are the object of intensive research: among these a decisive role is played by a biochemical sequence, involving activation of haeme oxygenase (HMO-1), whose effect appears mediated by carbon monoxide (CO). A central role in protection from malaria is also played by immunological factors, which may stimulate antibody production to plasmodium antigens in the early years of life; the role of agents like pathogenic CD8 T-cells has been suggested while the effects of molecular actions on the immunity mechanism are presently investigated. It thus appears that protection from malaria can be explained by interaction of different factors: the elucidation of such mechanisms may prove valuable for the prevention and treatment strategy of a disease which still affects large parts of the world.
Keywords: haemoglobin S; sickle cell trait; protection from malaria; haeme-oxygenase; immunity acquisition; CD8-Tcells haemoglobin S; sickle cell trait; protection from malaria; haeme-oxygenase; immunity acquisition; CD8-Tcells

Share and Cite

MDPI and ACS Style

Eridani, S. Sickle Cell Protection from Malaria. Hematol. Rep. 2011, 3, e24. https://doi.org/10.4081/hr.2011.e24

AMA Style

Eridani S. Sickle Cell Protection from Malaria. Hematology Reports. 2011; 3(3):e24. https://doi.org/10.4081/hr.2011.e24

Chicago/Turabian Style

Eridani, Sandro. 2011. "Sickle Cell Protection from Malaria" Hematology Reports 3, no. 3: e24. https://doi.org/10.4081/hr.2011.e24

Article Metrics

Back to TopTop